To include your compound in the COVID-19 Resource Center, submit it here.
The R.W. Johnson Pharmaceutical Research Institute, a JNJ subsidiary, said its Topamax topiramate
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury